Department of Orthopedic Surgery, Cleveland Clinic, Cleveland, OH.
Department of Orthopedic Surgery, Lenox Hill Hospital, New York, NY.
J Arthroplasty. 2019 Nov;34(11):2774-2779. doi: 10.1016/j.arth.2019.05.012. Epub 2019 May 13.
In revision total knee arthroplasty (rTKA) and revision total hip arthroplasty (rTHA), venous thromboembolism (VTE) has been reported to be a relatively common and potentially serious complication. To mitigate this risk, strategies such as rapid recovery programs and thromboprophylaxis guidelines have been utilized. This study sought to identify the annual incidence and recent trends of VTE (defined as the presence of deep vein thrombosis [DVT] and/or pulmonary embolism [PE] in the same patient), DVT, PE, and mortality in the 30-day period after rTKA and rTHA.
We identified 30,406 rTKA and rTHA patients from 2008 to 2016 using the National Surgical Quality Improvement Program database. Thirty-day incidences for VTE, DVT, PE, and mortality for each year and the overall study period were calculated. Bivariate and multivariate regressions were performed using patient demographics and comorbidities to assess trends in the outcomes of interest.
The overall incidences of 30-day VTE, DVT, PE, and mortality for rTKA were 1.2%, 0.9%, 0.4%, and 0.5%. Bivariate analysis revealed no significant change over the study period for VTE (P = .137), DVT (P = .406), PE (P = .121; 99% confidence interval 0.112-0.129), and mortality (P = .463). The incidences over the study period of VTE, DVT, PE, and mortality in rTHA were 1.0%, 0.7%, 0.4%, and 0.7%. Bivariate analysis revealed no changes in VTE (P = .393), DVT (P = .376), and PE (P = .602). However, bivariate analysis revealed significant decrease in mortality (P = .010) over the study period.
Within 30 days of surgery, approximately 1 in 83 rTKA patients and 1 in 100 rTHA patients experienced a VTE. Furthermore, the rates of VTE remained largely unchanged from 2008 to 2016. Further research regarding the optimal individualized prophylaxis algorithm in rTKA and rTHA is warranted to prevent this complication. This study represents the first investigation of thromboembolic events in rTHA and rTKA.
在翻修全膝关节置换术(rTKA)和翻修全髋关节置换术(rTHA)中,静脉血栓栓塞症(VTE)是一种相对常见且潜在严重的并发症。为了降低这种风险,已经采用了快速康复方案和血栓预防指南等策略。本研究旨在确定 rTKA 和 rTHA 后 30 天内 VTE(定义为同一患者中存在深静脉血栓形成 [DVT] 和/或肺栓塞 [PE])、DVT、PE 和死亡率的年度发生率和近期趋势。
我们使用国家手术质量改进计划数据库,从 2008 年到 2016 年确定了 30406 例 rTKA 和 rTHA 患者。计算了每年和整个研究期间 30 天内 VTE、DVT、PE 和死亡率的发生率。使用患者人口统计学和合并症进行双变量和多变量回归,以评估相关结局的趋势。
rTKA 患者 30 天 VTE、DVT、PE 和死亡率的总体发生率分别为 1.2%、0.9%、0.4%和 0.5%。双变量分析显示,研究期间 VTE(P=.137)、DVT(P=.406)、PE(P=.121;99%置信区间 0.112-0.129)和死亡率(P=.463)均无显著变化。rTHA 患者研究期间 VTE、DVT、PE 和死亡率的发生率分别为 1.0%、0.7%、0.4%和 0.7%。双变量分析显示,VTE(P=.393)、DVT(P=.376)和 PE(P=.602)无变化。然而,双变量分析显示,死亡率在研究期间显著下降(P=.010)。
rTKA 术后 30 天内,约每 83 例患者中有 1 例和 rTHA 术后每 100 例患者中有 1 例发生 VTE。此外,2008 年至 2016 年 VTE 发生率基本保持不变。需要进一步研究 rTKA 和 rTHA 中最佳个体化预防方案,以预防这种并发症。本研究代表了对 rTHA 和 rTKA 中血栓栓塞事件的首次调查。